Search

Progress on Development of RNA Base Editing Technologies for Precision Medicines

Presentation

Progress on Development of RNA Base Editing Technologies for Precision Medicines, including Axiomer® platform presented at TIDES EU by Gerard Platenburg - ProQR Therapeutics

november 18, 2022
Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders

Presentation

The presentation reviews EONs structure activity, the potential of the Axiomer platform as well as its applicability for the treatment of liver originated disorders. Presented at TIDES USA on May 9, 2023 by Gerard Platenburg - ProQR Therapeutics.

mei 09, 2023
ProQR Update August 2022

Community news

ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple therapeutic areas. This comes following feedback from the European Medicines Agency (EMA) related to ProQR’s sepofarsen for Leber Congenital Amaurosis type 10 (LCA10).

augustus 11, 2022
ProQR at TIDES to highlight our Axiomer® technology

Blog

This month several ProQRians will attend the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 to highlight our Axiomer® RNA-editing platform technology.

november 17, 2022
Harnessing chemical modifications to improve ADAR potency and unlock Axiomer broad applicability

Presentation

RNA Editing Summit (2023) Lenka Van Sint Fiet

juli 14, 2023
Development of RNA Base Editing Technologies for Precision Medicines

Presentation

… Development of RNA Base Editing Technologies for Precision Medicines Development of RNA Base Editing Technologies for Precision Medicines with …

mei 11, 2022
Unlocking the Potential of Innovative Editing Oligonucleotides to Address Liver Originated Disorders

Presentation

Axiomer platform presentation highlighting the potential of Editing Oligonucleotides (EONs) to address liver originated disorders. Presented at the RNA Editing Gordon Research Conference on March 23, 2023 by Gerard Platenburg - ProQR Therapeutics.

maart 23, 2023
Exploring why companies partner their technology

Blog

Partnerships in our industry are very common as companies look to benefit from knowledge and resource sharing. In this blog we explore why companies, like ProQR, partner with other companies.

januari 03, 2023
Analyst & Investor Axiomer® technology R&D Event

Presentation

This virtual event on March 29, 2023 featured presentations by ProQR Management on the company's proprietary Axiomer® RNA editing technology platform, detailed the initial pipeline targets, and provided guidance on the advancement of programs toward the clinic. ProQR also reported its 2022 year-end financials and the extension of its cash runway guidance.

maart 29, 2023
Catching up with returning ProQRian René Beukema

Blog

In this personal interview, we speak to ProQR’s Chief Corporate Development Officer & General Counsel, René Beukema on his return to ProQR.

februari 09, 2023